Texas Oncology Expands in RGV to Provide Surgical Oncology Services 

Translate to Spanish or other 102 languages!

Texas Oncology, one of the largest community-based oncology practices in the U.S., announced today the expansion of its services in the Rio Grande Valley region to include surgical oncology, with the addition of Vijian Dhevan, M.D., MBA, FACS to the physician team. Dr. Dhevan is board-certified in general surgery and has expertise in surgical oncology, as well as bariatric, pediatric (non-oncology procedures), and robotic surgery.  Courtesy Image
Texas Oncology, one of the largest community-based oncology practices in the U.S., announced today the expansion of its services in the Rio Grande Valley region to include surgical oncology, with the addition of Vijian Dhevan, M.D., MBA, FACS to the physician team. Dr. Dhevan is board-certified in general surgery and has expertise in surgical oncology, as well as bariatric, pediatric (non-oncology procedures), and robotic surgery. Courtesy Image

Mega Doctor News

- Advertisement -

HARLINGEN, Texas – Texas Oncology, one of the largest community-based oncology practices in the U.S., announced today the expansion of its services in the Rio Grande Valley region to include surgical oncology, with the addition of Vijian Dhevan, M.D., MBA, FACS to the physician team. Dr. Dhevan is board-certified in general surgery and has expertise in surgical oncology, as well as bariatric, pediatric (non-oncology procedures), and robotic surgery. 

“For more than 30 years, Texas Oncology has led the way in providing high-quality cancer care locally to patients in the Valley. Adding surgical oncology is a major step forward in expanding the cancer care services that we provide patients,” said Billie J. Marek, M.D. FACP, medical oncologist and medical director of Texas Oncology in the Rio Grande Valley. “Dr. Dhevan brings significant additional experience and surgical expertise to our practice, along with a recognized commitment to compassionate patient care and community involvement.”

With more than 11 years of experience, Dr. Dhevan performs surgery at three area hospitals, DHR Health Brownsville, Harlingen Medical Center, and Valley Baptist Medical Center – Harlingen. He will practice at Texas Oncology Surgical Specialists–Harlingen at 1649 Treasure Hills Blvd., Suite B-11 in Harlingen.  

- Advertisement -

“Texas Oncology prioritizes multidisciplinary cancer care so that patients have access to multiple treatment options, including surgery, which is my focus,” said Dr. Dhevan. “Advancements in minimally invasive surgical techniques, together with innovations in screenings and diagnostics, are a powerful combination that is delivering greater hope to cancer patients.”

Dr. Dhevan joins Texas Oncology’s growing Rio Grande Valley practice, which includes 18 physicians and nine advanced practice providers, along with a team of more than 225 additional clinical and administrative support staff. Texas Oncology provides comprehensive, leading-edge cancer care to patients at four Valley region locations, in Brownsville, Harlingen, McAllen, and Weslaco. 

For more information about Texas Oncology’s services in the Rio Grande Valley visit TexasOncology.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Children’s Free Food Safety Webinar for Parents on July 15th

Every meal should help children grow and thrive, not put their health at risk.

STHS Heart Earns National Recognition for Exceptional Stroke Care

Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in the United States, accounting for nearly three in 10 deaths nationwide and claiming more than 940,000 lives each year, according to the Centers for Disease Control and Prevention (CDC).

STHS McAllen Recognized as National Leader in Stroke Care with 7th Consecutive Gold Plus Award

Stroke is the fifth-leading cause of death in the United States and one of the leading causes of serious long-term disability nationwide, according to the Stroke Awareness Foundation, affecting nearly 800,000 Americans each year.

Medicare’s New $50 GLP-1 Coverage: 7 Essential Facts to Know

For decades, it’s been against the law for Medicare to pay for weight-loss medication, but that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if they meet certain weight and health criteria.
- Advertisement -